
NeuroMetrix NURO
Geschäftsbericht 2024
hinzugefügt 31.03.2025
NeuroMetrix DPO 2011-2025 | NURO
DPO Jährlich NeuroMetrix
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 78.1 | 54.5 | 47.5 | 33.4 | 24.4 | 37.7 | 54.4 | 26.1 | 37.7 | 97.9 | 74.3 | 53.7 | 26.2 | 48.6 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 97.9 | 24.4 | 49.6 |
DPO Vierteljährlich NeuroMetrix
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110 | 75.5 | 28.5 | - | 44.1 | 49.5 | 66.6 | - | 61.8 | 50.6 | 57.8 | - | 44.7 | 46.9 | 33.8 | - | 24.2 | 26.2 | 63.9 | - | 72.4 | 21.1 | 39.7 | - | 65 | 60.7 | 31.4 | - | 32.8 | 25.4 | 24.8 | - | 33 | 42.6 | 55.2 | - | 86.4 | 163 | 113 | - | 74.7 | 72.8 | 62.7 | - | 50.9 | 58.8 | 46.5 | - | 50 | 40.1 | 41.4 | - | 49.7 | 51.7 | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 163 | 21.1 | 54.9 |
DPO anderer Aktien in der Medizinische Instrumente
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Baxter International
BAX
|
50.7 | $ 18.99 | 0.48 % | $ 9.68 B | ||
|
Becton, Dickinson and Company
BDX
|
59.3 | $ 200.87 | 0.22 % | $ 57.8 B | ||
|
BioLife Solutions
BLFS
|
130 | $ 24.43 | -1.81 % | $ 1.13 B | ||
|
Luminex Corporation
LMNX
|
45.3 | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
218 | - | -9.52 % | $ 20.6 M | ||
|
Ekso Bionics Holdings
EKSO
|
73.7 | $ 4.79 | 2.35 % | $ 96.6 M | ||
|
DENTSPLY SIRONA
XRAY
|
54.3 | $ 11.59 | -0.13 % | $ 2.36 B | ||
|
Antares Pharma, Inc.
ATRS
|
93.7 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
26.4 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
3.31 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
61.4 | - | -0.05 % | $ 10.3 B | ||
|
Varian Medical Systems, Inc.
VAR
|
39.5 | - | -0.02 % | $ 16.3 B | ||
|
Alcon
ALC
|
63.6 | $ 78.74 | -0.03 % | $ 40.4 B | ||
|
iRhythm Technologies
IRTC
|
12.6 | $ 170.09 | 0.58 % | $ 5.31 B | ||
|
AtriCure
ATRC
|
81.2 | $ 42.08 | 1.62 % | $ 1.98 B | ||
|
Atrion Corporation
ATRI
|
31.9 | - | - | $ 810 M | ||
|
electroCore
ECOR
|
279 | $ 4.81 | -0.21 % | $ 26.5 K | ||
|
Harvard Bioscience
HBIO
|
47.4 | $ 0.76 | 1.78 % | $ 32.2 M | ||
|
AngioDynamics
ANGO
|
96.2 | $ 13.12 | -2.42 % | $ 536 M | ||
|
The Cooper Companies
COO
|
72.6 | $ 81.82 | -0.36 % | $ 16.3 B | ||
|
ICU Medical
ICUI
|
34.9 | $ 147.72 | 0.34 % | $ 3.6 B | ||
|
Glaukos Corporation
GKOS
|
67.2 | $ 109.57 | 0.31 % | $ 5.31 B | ||
|
Haemonetics Corporation
HAE
|
41.9 | $ 83.2 | -1.49 % | $ 4.19 B | ||
|
InfuSystem Holdings
INFU
|
62.5 | $ 9.24 | 0.33 % | $ 191 M | ||
|
Isoray
ISR
|
58.4 | - | 0.03 % | $ 108 M | ||
|
Repro Med Systems
KRMD
|
52 | $ 5.75 | -1.88 % | $ 262 M | ||
|
LeMaitre Vascular
LMAT
|
14.5 | $ 83.51 | 0.18 % | $ 1.87 B | ||
|
Intuitive Surgical
ISRG
|
25.7 | $ 541.3 | -1.11 % | $ 192 B | ||
|
Masimo Corporation
MASI
|
84.4 | $ 138.1 | -2.25 % | $ 7.36 B | ||
|
Merit Medical Systems
MMSI
|
34.4 | $ 86.52 | -0.01 % | $ 5.04 B | ||
|
Microbot Medical
MBOT
|
52.9 | $ 2.43 | 2.21 % | $ 24.8 M | ||
|
Milestone Scientific
MLSS
|
36.5 | $ 0.39 | 9.69 % | $ 31.1 M | ||
|
Nephros
NEPH
|
50.5 | $ 5.08 | 2.24 % | $ 52.8 M | ||
|
ResMed
RMD
|
34.9 | $ 250.7 | -0.67 % | $ 36.6 B | ||
|
Envista Holdings Corporation
NVST
|
56.8 | $ 21.79 | -1.58 % | $ 3.75 B | ||
|
OraSure Technologies
OSUR
|
36.6 | $ 2.52 | -2.14 % | $ 188 M | ||
|
Pro-Dex
PDEX
|
35.4 | $ 43.83 | 0.6 % | $ 144 M | ||
|
Pulse Biosciences
PLSE
|
68.4 | $ 14.26 | 3.71 % | $ 685 M | ||
|
Predictive Oncology
POAI
|
547 | $ 5.95 | 0.51 % | $ 32.4 M | ||
|
Repligen Corporation
RGEN
|
24.3 | $ 156.65 | -3.1 % | $ 8.73 M | ||
|
Retractable Technologies
RVP
|
48.6 | $ 0.83 | -0.31 % | $ 24.8 M | ||
|
STAAR Surgical Company
STAA
|
74.3 | $ 24.16 | -2.11 % | $ 1.19 B | ||
|
STERIS plc
STE
|
31.8 | $ 251.01 | -0.59 % | $ 24.7 B | ||
|
Stereotaxis
STXS
|
99 | $ 2.38 | -1.45 % | $ 192 M | ||
|
Teleflex Incorporated
TFX
|
37.1 | $ 125.81 | -1.13 % | $ 5.89 B | ||
|
Utah Medical Products
UTMD
|
18 | $ 57.99 | 0.5 % | $ 210 M | ||
|
West Pharmaceutical Services
WST
|
46.4 | $ 266.92 | -2.06 % | $ 19.5 B |